Drug pipeline
Full profile accessExplore the programs pursuing this target and their development progress.
- Drug candidates
- Developers
- Development stage
Target intelligence / Profile preview
The "RevCAR epitope" is a synthetic peptide tag—most often either “E5B9” or “E7B6”—derived from human La/SS-B protein sequences. It is displayed on engineered immune effector cells’ surfaces as part of advanced chimeric antigen receptor designs. Its primary function is enabling highly specific engagement with externally administered bispecific adaptors (RevTMs), allowing flexible redirection against diverse cancer targets with improved safety profiles compared to conventional direct-targeting CAR systems.
Recruits T cells to tumor cells via bispecific adaptors (RevTMs)
Beyond the preview
Explore the evidence, development activity, and competitive landscape with Gosset’s full data platform.
Explore the programs pursuing this target and their development progress.
Follow the clinical studies evaluating therapies directed at this target.
Compare approaches across drug candidates, modalities, and indications.
Investigate the research and source evidence behind target biology and development.
Explore patent activity around therapies and technologies addressing this target.
Connect target biology, drug development, and emerging evidence in your research.
See how Gosset can support your research on RevCAR Epitope (N/A).